# Bevacizumab and Vasoconstriction

> **NCT00929058** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Hypertension
- Cancer

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00929058
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929058, "Bevacizumab and Vasoconstriction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00929058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*